Overview
Financials
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 4 financial statements were filed late (the longest delay 641 days for 2021).
- 2025not filed
- 202407/06/2025
- 202316/04/2024
- 202216/04/2024
- 202116/04/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the President of the Management Board acting independently, or a member of the management board acting jointly with a commercial proxy, is authorised to represent the company externally, make declarations on behalf of the company, and conduct the company's affairs.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Anna Henryka Bajerage 44 | 90 | $1,215.56 | 90% |
Jadwiga Bajerage 69 | 10 | $135.06 | 10% |
Anna Henryka Bajer and Jadwiga Bajer hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
No beneficial owners recorded for the company Gaba-Med.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Hammermed Medical PolskaS.K.A. | $93,061,305.58 | hammer.pl | ||
| Novama CloudS.A. | $8,295,437.50 | novama.cloud | ||
| Euroleki Gksp. z o.o. + limited partnership | $6,866,421.91 | euroleki.eu | ||
| Ana-Medsp. z o.o. | $5,202,905.16 | ana-med.eu | ||
| TDFS.A. | $5,168,316.22 | tdfsa.pl | ||
| Geneco Groupsp. z o.o. | $156,220.50 | genecocontact.pl | ||
| Novaova Sosnowski Wadowskisp. k. | $54,452.69 | novaova.pl | ||
| Endolink PharmaS.A. | $7,191.18 | endolink.pl | ||
| Novaovasp. z o.o. | $0.16 | novaova.pl | ||
| Mezofillsp. z o.o. | – | mezofill.pl |
FAQ
Last updated: 2026-04-26